Immunosuppressive therapy in inflammatory cardiomyopathy

European Heart Journal, Supplement

Volumn 4, Issue I, 2002, Pages

  Frustaci, A ^a   Pieroni, M ^a   Chimenti, C ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

Autoantibodies; Immunosuppression; Inflammatory cardiomyopathy; Viruses

Indexed keywords

AZATHIOPRINE; BETA INTERFERON; DIGITALIS; ENALAPRIL; FUROSEMIDE; IMMUNOSUPPRESSIVE AGENT; PREDNISONE;

CARDIOMYOPATHY; CLINICAL TRIAL; CONFERENCE PAPER; CONGESTIVE HEART FAILURE; CONNECTIVE TISSUE DISEASE; DRUG EFFICACY; DRUG RESPONSE; GRAFT REJECTION; HEPATITIS C VIRUS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MYOCARDITIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; VIRUS DETECTION; VIRUS MYOCARDITIS;

EID: 0036897991     PISSN: 1520765X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1520-765X(02)90114-8     Document Type: Conference Paper

References (33)

1. Richardson P, McKenna W, Bristow M, et al. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of Cardiomyopathies. Circulation 1996; 93: 841-2.
2. Feldman AM, McNamara D. Myocarditis. N Engl J Med 2000; 343: 1388-98.
3. Chimenti C, Calabrese F, Thiene G, et al. Inflammatory left ventricular microaneurysms as a cause of apparently idiopathic ventricular tachyarrhythmias. Circulation 2001; 104: 168-73.
4. Narula J, Khaw BA, Dec GW Jr, et al. Brief report: Recognition of acute myocarditis masquerading as acute myocardial infarction. N Engl J Med 1993; 328: 100-4.
5. Angelini A, Calzolari V, Calabrese F, et al. Myocarditis mimicking acute myocardial infarction: Role of endomyocardial biopsy in the differential diagnosis. Heart 2000; 84: 245-50.
6. Frustaci A, Chimenti C, Maseri A. Global bi-ventricular dysfunction in patients with symptomatic coronary artery disease may be bc caused by myocarditis. Circulation 1999; 99: 1295-9.
7. Mason JW, O'Connell JB, Herskowitz A, et al. A clinical trial of immunosuppressive therapy for myocarditis. N Engl J Med 1995; 333: 269-75.
8. Aretz H, Billingham ME, Edwards WD, et al. Myocarditis. A histopatologic definition and classification. Am J Cardiovasc Pathol 1986; 1: 3-14.
9. Kuhl U, Seeberg B, Schultheiss HP, et al. Immunohistological characterization of infiltrating lymphocytes in biopsies of patients with clinically suspected dilated cardiomyopathy. Eur Heart J 1994; 15: 62-7.
10. Pauschinger M, Bowles NE, Fuentes-Garcia FJ, et al. Detection of adenoviral genome in the myocardium of adult patients with idiopathic left ventricular dysfunction. Circulation 1999; 99: 1348-54.
11. Pauschinger M, Doerner A, Kuehl U, et al. Enteroviral RNA replication in the myocardium of patients with left ventricular dysfunction and clinically suspected myocarditis. Circulation 1999; 99: 889-95.
12. Noutsias M, Fechner H, de Jonge H, et al. Human coxsackie-adenovirus receptor is colocalized with integrins alpha(v)beta(3) and alpha(v)beta(5) on the cardiomyocyte sarcolemma and upregulated in dilated cardiomyopathy: Implications for cardiotropic viral infections. Circulation 2001; 104: 275-80.
13. Badorff C, Lee GH, Lamphear BJ, et al. Enteroviral protease 2A cleaves dystrophin: Evidence of cytoskeletal disruption in an acquired cardiomyopathy. Nat Med 1999; 5: 320-6.
14. Chan KY, Iwahara A, Benson LN, et al. Immunosuppressive therapy in the management of acute myocarditis in children; a clinical trial. J Am Coll Cardiol 1991; 17: 458-60.
15. Matitiau A, Perez-Atayde A, Sanders SP, et al. Infantile dilated cardiomyopathy. Relation of outcome to left ventricular mechanics, hemodynamics, and histology at the time of presentation. Circulation 1994; 90: 1310-8.
16. Lee KJ, McCrindle BW, Bohn DJ, et al. Clinical outcomes of acute myocarditis in childhood. Heart 1999; 82: 226-33.
17. Kleinert S, Weintraub RG, Wilkinson JL, et al. Myocarditis in children with dilated cardiomyopathy: Incidence and outcome after dual therapy immunosuppression. J Heart Lung Transplant 1997; 16: 1248-54.
18. Parrillo JE, Cunnion RE, Epstein SE, et al. A prospective, randomized, controlled trial of prednisone for dilated cardiomyopathy. N Engl J Med 1989; 321: 1061-8.
19. Kuhl U, Schultheiss HP. Treatment of chronic myocarditis with corticosteroids. Eur Heart J 1995; 16(suppl O): 168-72.
20. Frustaci A, Gentiloni N, Chimenti C, et al. Necrotizing myocardial vasculitis in Churg-Strauss syndrome: clinicohistologic evaluation of steroids and immunosuppressive therapy. Chest 1998; 114: 1484-9.
21. Badorff C, Schwimmbeck PL, Kuhl U, et al. Cardiac sarcoidosis: Diagnostic validation by endomyocardial biopsy and therapy with corticosteroids. Z Kardiol 1997; 86: 9-14.
22. Cooper LT Jr, Berry GJ, Shabetai R. Idiopathic giant-cell myocarditis-natural history and treatment. Multicenter Giant Cell Myocarditis Study Group Investigators. N Engl J Med 1997; 336: 1860-6.
23. Frustaci A, Chimenti C, Pieroni M, et al. Giant cell myocarditis responding to immunosuppressive therapy. Chest 2000; 117: 905-7.
24. Frustaci A, Gentiloni N, Caldarulo M. Acute myocarditis and left ventricular aneurysm as presentations of systemic lupus erythematosus. Chest 1996; 109: 282-4.
25. Billingham ME. Can histopathology guide immunosuppression for cardiac allograft rejection in the light of new techniques? Transplant Proc 1997; 29: 35S-6S
26. Dec GW Jr, Palacios IF, Fallon JT, et al. Active myocarditis in the spectrum of acute dilated cardiomyopathies. Clinical features, histologic correlates, and clinical outcome. N Engl J Med 1985; 312: 885-90.
27. Wojnicz R, Nowalany-Kozielska E, Wojciechowska C, et al. Randomized, placebo-controlled study for immunosuppressive treatment of inflammatory dilated cardiomyopathy: Two-year follow-up results. Circulation 2001; 104: 39-45.
28. Chimenti C, Pieroni M, Calabrese F, et al. Active lymphocytic myocarditis: Virologic and immunologic profile of responders vs non-responders to immunosuppressive therapy [abstract 2644]. Circulation 2001; 104(suppl).
29. Kilbourne ED, Wilson CB, Perrier D. The induction of gross myocardial lesions by a coxsackie (pleurodynia) virus and cortisone. J Clin Invest 1956; 35: 362-70.
30. Kishimoto C, Thorp KA, Abelmann WH. Immunosuppression with high doses of cyclophoshamide reduces the severity of myocarditis but increases the mortality in murine coxsackievirus B3 myocarditis. Circulation 1990; 82: 982-9.
31. Kuhl U, Pauschinger M, Schwimmbeck PL, et al. Interferon-β treatment of patients with enteroviral and adenoviral cardiomyopathy causes effective virus clearance and long-term clinical improvement [abstract]. Circulation 2001; 104(suppl): 3220.
32. Gutfreund KS, Bain VG. Chronic viral hepatitis C: Management update. CMAJ 2000; 16: 827-33.
33. Martin AB, Webber S, Fricker FJ, et al. Acute myocarditis. Rapid diagnosis by PCR in children. Circulation 1994; 90: 330-9.